Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Hafner

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Plos Computational Biology|March 17, 2012
Effect of network architecture on synchronization and entrainment properties of the circadian oscillations in the suprachiasmatic nucleusMarc Hafner, Heinz Koeppl, Didier Gonze
BMC Bioinformatics|November 26, 2013
Mapping behavioral specifications to model parameters in synthetic biologyHeinz Koeppl, Marc Hafner, James Lu
Nature Biotechnology|June 8, 2017
Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomicsMarc Hafner, Mario Niepel, Peter K Sorger
Plos Computational Biology|October 17, 2009
'Glocal' robustness analysis and model discrimination for circadian oscillatorsMarc Hafner, Heinz Koeppl, Martin Hasler, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|May 19, 2012
Explaining the length threshold of polyglutamine aggregationPaolo De Los Rios, Marc Hafner, Annalisa Pastore
Current Protocols in Chemical Biology|June 20, 2017
Measuring Cancer Drug Sensitivity and Resistance in Cultured CellsMario Niepel, Marc Hafner, Mirra Chung, et al.
Nature Methods|May 3, 2016
Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugsMarc Hafner, Mario Niepel, Mirra Chung, et al.
Current Protocols in Chemical Biology|June 20, 2017
Designing Drug-Response Experiments and Quantifying their ResultsMarc Hafner, Mario Niepel, Kartik Subramanian, et al.
BMC Systems Biology|September 17, 2011
Efficient characterization of high-dimensional parameter spaces for systems biologyElías Zamora-Sillero, Marc Hafner, Ariane Ibig, et al.
The Journal of Biological Chemistry|March 13, 2019
A multitargeted probe-based strategy to identify signaling vulnerabilities in cancersSuman Rao, Guangyan Du, Marc Hafner, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Plos Computational Biology|March 17, 2012
Effect of network architecture on synchronization and entrainment properties of the circadian oscillations in the suprachiasmatic nucleusMarc Hafner, Heinz Koeppl, Didier Gonze
BMC Bioinformatics|November 26, 2013
Mapping behavioral specifications to model parameters in synthetic biologyHeinz Koeppl, Marc Hafner, James Lu
Nature Biotechnology|June 8, 2017
Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomicsMarc Hafner, Mario Niepel, Peter K Sorger
Plos Computational Biology|October 17, 2009
'Glocal' robustness analysis and model discrimination for circadian oscillatorsMarc Hafner, Heinz Koeppl, Martin Hasler, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|May 19, 2012
Explaining the length threshold of polyglutamine aggregationPaolo De Los Rios, Marc Hafner, Annalisa Pastore
Current Protocols in Chemical Biology|June 20, 2017
Measuring Cancer Drug Sensitivity and Resistance in Cultured CellsMario Niepel, Marc Hafner, Mirra Chung, et al.
Nature Methods|May 3, 2016
Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugsMarc Hafner, Mario Niepel, Mirra Chung, et al.
Current Protocols in Chemical Biology|June 20, 2017
Designing Drug-Response Experiments and Quantifying their ResultsMarc Hafner, Mario Niepel, Kartik Subramanian, et al.
BMC Systems Biology|September 17, 2011
Efficient characterization of high-dimensional parameter spaces for systems biologyElías Zamora-Sillero, Marc Hafner, Ariane Ibig, et al.
The Journal of Biological Chemistry|March 13, 2019
A multitargeted probe-based strategy to identify signaling vulnerabilities in cancersSuman Rao, Guangyan Du, Marc Hafner, et al.
Pageof 6